The hybrid cells promote tumor heterogeneity and possible metastasis, a new study in mice and humans shows.

The researchers catalogued 3,893 variants of the gene implicated in cancer using CRISPR.

José Baselga of Memorial Sloan Kettering took millions of dollars from drug and health care companies but did not report the payments in his research articles.

Cancer treatments from Novartis and Gilead earn approval from EU regulators, but a first pass by the UK’s state-funded health service finds CAR T is too expensive. 

DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.

A San Francisco court levels $289 Million in damages against the pesticide maker.

The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.

The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.

The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.